MMP9 and ischemic stroke: As MMP-9 was the primary proteolytic enzyme, which was reported to degrade claudin-5 and ZO-1 after ischemic stroke, Con-exo significantly inhibited the level of MMP-9 compared with the MCAO group (P < 0.01; Figures 3C,D).